Pharmacokinetic (PK)/pharmacodynamic (PD) trial of the new generation platinum compound ZD0473 administered as an iv infusion every 21 days

Autor: Stevenson, J.P., Blair, I.A., Redlinger, M., Sun, W., Oe, T., Koehler, M., Roberts, D.W., Malone, M.D., O'Dwyer, P.J.
Zdroj: In European Journal of Cancer 2001 37 Supplement 6:S72-S72
Databáze: ScienceDirect